Vimta Labs, a company in the Healthcare Research, Analytics & Technology industry, reported revenue of ₹112 crore and net profit of ₹21 crore for the September 2026 quarter.
Vimta Labs (NSE: VIMTALABS) closed at ₹467.65 on 20 Nov 2026, down 24.6% over the past year. Its market capitalisation is ₹2,090 crore and it trades at 25.7 times earnings.
Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.